Cite

HARVARD Citation

    Zou, Y. et al. (n.d.). Bortezomib and lenalidomide as front-line therapy for multiple myeloma. Leukemia & lymphoma. 55 (9), pp. 2024-2031. [Online]. 
  
Back to record